Knight Therapeutics | GUD - Ebit


Knight Therapeutics reported CAD6.21M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -952K 60K Jun/2026
Aurora Cannabis CAD -3.17M 10.29M Jun/2026
Avita Medical AUD -6.17M 4.22M Jun/2026
Canopy Growth CAD -2.03M 143.62M Jun/2026
Cronos Group USD 96.96M 89.36M Sep/2026
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Moderna USD 130M 945M Sep/2026
Omeros USD -48.15M 7.25M Sep/2023
Organigram Holdings CAD 5.33M 15.12M Jun/2026
Organon & Co USD 377M 86M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD 255.5M 181.8M Sep/2026
Xeris Pharmaceuticals USD -24.15M 33.27M Jun/2026